PCV21 Patient Characteristics and Dosage Patterns of Statin Users in Japan: A Health Care Database Analysis von Zhao, Z, Zhu, Y, McCollam, P.L, Molife, C, Sponseller, C.A, Kryzhanovski, V

Volltext

MA1 Medication Adherence and Persistence of Prasugrel Initiators Post ACS-PCI von Simeone, J.C, Nordstrom, B, Zhao, Z, Molife, C, Mccollam, P.L, Ye, X, Effron, M.B

Volltext

PCV118 Characteristics of Patients Treated with Thienopyridines Following ACS-PCI von Nordstrom, B, Simeone, J.C, Zhao, Z, Molife, C, Mccollam, P.L, Ye, X, Effron, M.B

Volltext

94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastati... von Fang, J., Zhao, Y., Han, B., Chen, G., Yang, Z., Bi, M., Zhang, L., Molife, C.

Volltext

PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims Database von Molife, C, Zhu, Y, Yu, C, Mccracken, R, Zhao, Z

Volltext

P2.01-75 Temporal Trends in Treatment Patterns for Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Routine Clinical Practice von Stefaniak, V., Winfree, K., Cui, Z., Molife, C.

Volltext

86P Adjusting ORIENT-11 trial (O-11) results to a US patient population von Nagasaka, M., Cui, Z.L., Stefaniak, V.J., Li, X., Kim, S., Lee, H-Y.C., Beyrer, J.K., Molife, C.

Volltext

P10.04 A Budget Impact Analysis for Treatment with Ramucirumab Plus Erlotinib in Metastatic EGFR-Mutated NSCLC in the US von Nilsson, J., Winfree, K., Molife, C., Bhattacharyya, D., D'Yachova, Y., Wang, X., Malmenäs, M., Taipale, K.

Volltext

MO01.17 Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations von Winfree, K., Molife, C., Peterson, P., Chen, Y., Visseren, C., Beyrer, J., Leusch, M., Dimou, A.

Volltext

CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and N... von Garassino, M, Brnabic, A, Stefaniak, V, Belger, M, Gruver, K, Chen, JV, Souri, S, Molife, C, Blumenschein, G

Volltext

PCV135 Low Lipoprotein Cholesterol Goal Attainment in Dyslipidemic Patients with Existing Statin therapy: A Chart Extraction-Based Approach von Ivanova, J, Frois, C, Bae, J.P, Boykin, S.D, Mccracken, R, Molife, C, Waldman, T, Zhao, Z

Volltext

PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy: A Chart Extraction-Based Approach von Zhao, Z, Ivanova, J, Bae, J.P, Boykin, S.D, Mccracken, R, Molife, C, Waldman, T, Frois, C

Volltext

1357P Outcomes of treated patients with EGFR-mutated advanced or metastatic non-small cell lung cancer harboring exon 19 deletions or L858R substitution (Exon 21) mutations: A syst... von Winfree, K.B., Wang, X., Kiiskinen, U., Reppen, G., Papagiannopoulos, C., Nassim, M., Haeussler, K., So, D., Taipale, K., Molife, C., Jen, M-H., Traore, S., Varea, R.

Volltext

P3.01-110 Defining Aggressive Disease in Patients With Advanced NSCLC Receiving Second-Line Treatment: A Systematic Review von Winfree, K., Ainsworth, C., Njue, A., Molife, C., Lyall, M., Jen, M., Bittoni, M., Heyes, A., Carbone, D.

Volltext

P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients von Batus, M., Molife, C., Clarke, J., Stefaniak, V., Winfree, K., Cui, Z., Han, Y., Tawney, M., Bonomi, P.

Volltext

P3.01-19 Sequencing of Ramucirumab+Docetaxel Post-Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients von Clarke, J., Stefaniak, V., Batus, M., Winfree, K., Molife, C., Cui, Z., Han, Y., Tawney, M., Bonomi, P.

Volltext

CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learning... von Pennell, NA, Clarke, JM, Liu, S, Gutierrez, M, Batus, M, Bauman, J, Fidler, MJ, Marmarelis, ME, Feliciano, J, Barzi, A, Lopes, G, Molife, C, Verma, S, Stefaniak, VJ, Winfree, KB, Belli, A, Cui, Z, Kim, S, Manion, C, Afolabi, M, Caria, N, Bonomi, P

Volltext

PS02.18 Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Community Practice Setting: Topic: Medical Oncology von Zhang, L., Cuyun Carter, G., Beyrer, J., Li, L., Sheffield, K., Muehlenbein, C., Boye, M., Molife, C., Frantz, K., John, W., Gadgeel, S.M.

Volltext

PS02.18 Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Community Practice Setting von Zhang, L., Cuyun Carter, G., Beyrer, J., Li, L., Sheffield, K., Muehlenbein, C., Boye, M., Molife, C., Frantz, K., John, W., Gadgeel, S.M.

Volltext

PDB61 PREDICTORS OF INSULIN DELIVERY SYSTEM USE IN PATIENTS WITH TYPE 2 DIABETES von Molife, C, Hayes, RP

Volltext